XML 48 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Common Stock and Stock Plans (Tables)
12 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Summary of Stock-based Compensation Expense

Total stock-based compensation expense recognized in accordance with the authoritative guidance for share-based payments was as follows:

 

 

 

Fiscal Years Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

March 31, 2022

 

 

 

(In thousands)

 

Stock-based compensation expense before taxes

 

$

83,631

 

 

$

82,112

 

 

$

84,981

 

Related income tax benefits

 

 

(5,292

)

 

 

(17,238

)

 

 

(19,809

)

Stock-based compensation expense, net of taxes

 

$

78,339

 

 

$

64,874

 

 

$

65,172

 

Summary of Employee Stock Options and Employee Stock Purchase Plan Weighted Average Assumptions The weighted average assumptions (annualized percentages) used in the Black-Scholes model and Monte Carlo simulation were as follows:

 

 

 

Stock Options

 

 

Market-based Performance Stock Options

 

 

Employee Stock Purchase Plan

 

 

 

Fiscal Year
2024

 

 

Fiscal Year
2023

 

 

Fiscal Year
2022

 

 

Fiscal Year
2024

 

 

Fiscal Year
2023

 

 

Fiscal Year
2022

 

 

Fiscal Year
2024

 

 

Fiscal Year
2023

 

 

Fiscal Year
2022

 

Volatility

 

 

54.2

%

 

 

46.4

%

 

 

49.5

%

 

 

56.4

%

 

 

49.9

%

 

 

42.5

%

 

 

66.6

%

 

 

60.5

%

 

 

42.1

%

Risk-free interest rate

 

 

4.2

%

 

 

3.4

%

 

 

0.4

%

 

 

4.4

%

 

 

3.8

%

 

 

1.2

%

 

 

5.3

%

 

 

3.4

%

 

 

0.1

%

Dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Expected life

 

5.0 years

 

 

5.0 years

 

 

3.2 years

 

 

4.6 years

 

 

5.0 years

 

 

5.0 years

 

 

0.5 years

 

 

0.5 years

 

 

0.5 years

 

Summary of Stock Option Activity and TSR Performance Stock Option Activity

A summary of stock option activity for fiscal year 2024 is presented below:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise Price
per Share

 

 

Weighted Average
Remaining
Contractual
Term in Years

 

 

Aggregate
Intrinsic
Value
(In thousands)

 

Outstanding at March 31, 2023

 

 

236,496

 

 

$

62.53

 

 

 

 

 

 

 

Options granted

 

 

58,000

 

 

 

31.00

 

 

 

 

 

 

 

Options expired

 

 

(69,914

)

 

 

71.12

 

 

 

 

 

 

 

Options exercised

 

 

(2,633

)

 

 

31.28

 

 

 

 

 

 

 

Outstanding at March 31, 2024

 

 

221,949

 

 

$

51.95

 

 

 

3.2

 

 

$

 

Vested and exercisable at March 31, 2024

 

 

163,949

 

 

$

59.36

 

 

 

2.4

 

 

$

 

A summary of market-based performance stock option activity for fiscal year 2024 is presented below:

 

 

 

Number of
Shares (1)

 

 

Weighted
Average
Exercise Price
per Share

 

 

Weighted Average
Remaining
Contractual
Term in Years

 

 

Aggregate
Intrinsic
Value
(In thousands)

 

Outstanding at March 31, 2023

 

 

2,407,312

 

 

$

48.06

 

 

 

 

 

 

 

Market-based performance options granted

 

 

1,513,923

 

 

 

19.72

 

 

 

 

 

 

 

Market-based performance options canceled

 

 

(564,252

)

 

 

71.83

 

 

 

 

 

 

 

Market-based performance options exercised

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2024

 

 

3,356,983

 

 

$

31.29

 

 

 

4.4

 

 

$

2,568,780

 

Vested and exercisable at March 31, 2024

 

 

 

 

$

 

 

 

 

 

$

 

 

(1)
Number of shares is based on the target number of options under each market-based performance stock option.
Summary of Restricted Stock Unit Activity A summary of restricted stock unit activity for fiscal year 2024 is presented below:

 

 

 

Number of
Restricted
Stock
Units

 

 

Weighted
Average Grant
Date Fair Value
per Share

 

Outstanding at March 31, 2023

 

 

4,465,147

 

 

$

43.00

 

Awarded

 

 

1,451,667

 

 

 

29.21

 

Forfeited

 

 

(352,651

)

 

 

40.89

 

Vested

 

 

(1,543,429

)

 

 

45.86

 

Outstanding at March 31, 2024

 

 

4,020,734

 

 

$

37.11

 

Vested and deferred at March 31, 2024

 

 

207,785

 

 

$

51.71